mounjaro tirzepatide news Weight-loss jab trial begins in Manchester Exciting News! Aspen Pharmaceuticals has

The strength of evidence regarding the effects of intermittent fasting on weight and cardiometabolic risk factors is weak compared to the strong, consistent evidence for the health benefits of a Mediterranean dietary pattern (Dinu et al

A new case series describes two patients with migraine who experienced fewer migraine attacks after starting tirzepatide, a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist

All peptides require reconstitution with Bacteriostatic water (BAC water), sold separately

Who is it for: Wegovy is recommended for pre-, peri- and post-menopausal women who qualify for weight loss treatments and would benefit from a holistic platform with 24/7 access to physicians and a supportive community of experts and other women in this life stage

This moralizing of weight-loss care isnt just outdated